Silver Gabrielle Alison
Insider CIK 1685532 · OPNT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 2,500 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 2,500 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 2,500 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 2,500 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer | 2023-03-02 | 2023-03-03 | 2,000 | $20.00 | $40.0K | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer | 2023-03-02 | 2023-03-03 | 21,343 | $20.00 | $426.9K | 2,000 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2022-06-14 | 2022-06-14 | 2,000 | — | $0 | 23,343 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | P Buy | 2022-05-16 | 2022-05-17 | 2,500 | $13.29 | $33.2K | 21,343 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award deriv | 2021-06-15 | 2021-06-16 | 2,500 | — | $0 | 2,500 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2021-06-15 | 2021-06-16 | 2,000 | — | $0 | 18,843 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise deriv | 2021-05-13 | 2021-05-13 | 365 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise | 2021-05-13 | 2021-05-13 | 365 | $10.00 | $3.6K | 16,843 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise deriv | 2021-03-17 | 2021-03-17 | 7,886 | $10.00 | $78.9K | 365 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise | 2021-03-17 | 2021-03-17 | 7,886 | $10.00 | $78.9K | 23,635 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2021-03-17 | 2021-03-17 | 7,157 | $11.07 | $79.2K | 16,478 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise deriv | 2021-03-16 | 2021-03-17 | 2,231 | $10.00 | $22.3K | 8,251 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2021-03-16 | 2021-03-17 | 1,949 | $11.50 | $22.4K | 15,749 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise | 2021-03-16 | 2021-03-17 | 2,231 | $10.00 | $22.3K | 17,698 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise deriv | 2021-03-15 | 2021-03-17 | 4,518 | $10.00 | $45.2K | 10,482 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise | 2021-03-15 | 2021-03-17 | 4,518 | $10.00 | $45.2K | 19,367 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | S Sale | 2021-03-15 | 2021-03-17 | 3,900 | $11.64 | $45.4K | 15,467 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise deriv | 2021-03-05 | 2021-03-08 | 8,334 | — | $0 | 15,000 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | M Exercise | 2021-03-05 | 2021-03-08 | 8,334 | $10.00 | $83.3K | 14,849 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award deriv | 2020-06-15 | 2020-06-15 | 2,500 | — | $0 | 2,500 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2020-06-15 | 2020-06-15 | 2,000 | — | $0 | 6,515 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | P Buy | 2020-06-10 | 2020-06-12 | 2,730 | $9.13 | $24.9K | 4,515 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | P Buy | 2019-11-22 | 2019-11-25 | 1,785 | $13.51 | $24.1K | 1,785 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award deriv | 2019-06-12 | 2019-06-13 | 2,500 | — | $0 | 2,500 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award deriv | 2018-06-13 | 2018-06-14 | 2,500 | $15.56 | $38.9K | 2,500 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award deriv | 2017-08-29 | 2017-08-31 | 11,667 | — | $0 | 23,334 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award deriv | 2016-12-13 | 2016-12-15 | 11,667 | — | $0 | 11,667 | SEC↗ |